Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Material Contracts

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-02-27: Form 10-K; Exhibit 10.9.B; Description First through Sixth Amendments to the Prothena Corporation plc 2018 Long Term Incentive Plan.
  • 2026-02-27: Form 10-K; Exhibit 10.4.B; Description Amendment Number One to Global License Agreement, dated as of October 15, 2025, by and between Prothena Biosciences Limited and Celgene Switzerland LLC.
  • 2025-08-04: Form 10-Q; Exhibit 10.2; Description Form of Restricted Share Unit Award Agreement between Prothena Corporation plc and its Named Executive Officers under the Prothena Corporation plc 2018 Long Term Incentive Plan.
  • 2025-07-30: Form 8-K; Exhibit 10.1; Description Form of Employment Agreement.
FiledFormExhibitDescription
2026-02-2710-K10.9.BFirst through Sixth Amendments to the Prothena Corporation plc 2018 Long Term Incentive Plan
2026-02-2710-K10.4.BAmendment Number One to Global License Agreement, dated as of October 15, 2025, by and between Prothena Biosciences Limited and Celgene Switzerland LLC

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10